Felix Böhm1, Magnus Settergren, John Pernow. 1. Department of Cardiology, Karolinska University Hospital, Solna, S-171 76 Stockholm, Sweden. felix.bohm@ki.se
Abstract
OBJECTIVE: Inflammation of the vessel wall is of importance in atherosclerosis. Endothelin-1 (ET-1) exerts pro-inflammatory effects and contributes to endothelial dysfunction. The objective was to test whether ET-1 impairs vascular function by increasing oxidative stress and release of pro-inflammatory cytokines in humans. METHODS: Forearm blood flow (FBF) was determined in 12 young healthy males with venous occlusion plethysmography. RESULTS: Intra-brachial infusion of ET-1 (20 pmol/min) decreased both endothelium-dependent and -independent vasodilatation (P<0.001). ET-1 also increased venous IL-6 levels (0.96+/-0.14-1.40+/-0.15 ng/ml; P<0.001). Administration of Vitamin C (24 mg/min) following the ET-1 infusion did not restore vascular function. However, pre-treatment with Vitamin C before ET-1 prevented the decrease in endothelium-dependent and -independent vasodilatation as well as the increase in IL-6 levels (1.20+/-0.28 versus 1.29+/-0.27 ng/ml; P=0.57). Infusion of a control vasoconstrictor substance, noradrenaline (80 ng/min) for 30 min did not affect IL-6 levels. CONCLUSIONS: ET-1 impairs endothelium-dependent and -independent vasodilatation and stimulates release of IL-6 in humans in vivo. These effects are inhibited by pre-treatment with the antioxidant Vitamin C. This suggests that the mechanism by which ET-1 impairs vascular function and stimulates release of IL-6 involves increased oxidative stress.
OBJECTIVE: Inflammation of the vessel wall is of importance in atherosclerosis. Endothelin-1 (ET-1) exerts pro-inflammatory effects and contributes to endothelial dysfunction. The objective was to test whether ET-1impairs vascular function by increasing oxidative stress and release of pro-inflammatory cytokines in humans. METHODS: Forearm blood flow (FBF) was determined in 12 young healthy males with venous occlusion plethysmography. RESULTS: Intra-brachial infusion of ET-1 (20 pmol/min) decreased both endothelium-dependent and -independent vasodilatation (P<0.001). ET-1 also increased venous IL-6 levels (0.96+/-0.14-1.40+/-0.15 ng/ml; P<0.001). Administration of Vitamin C (24 mg/min) following the ET-1 infusion did not restore vascular function. However, pre-treatment with Vitamin C before ET-1 prevented the decrease in endothelium-dependent and -independent vasodilatation as well as the increase in IL-6 levels (1.20+/-0.28 versus 1.29+/-0.27 ng/ml; P=0.57). Infusion of a control vasoconstrictor substance, noradrenaline (80 ng/min) for 30 min did not affect IL-6 levels. CONCLUSIONS:ET-1 impairs endothelium-dependent and -independent vasodilatation and stimulates release of IL-6 in humans in vivo. These effects are inhibited by pre-treatment with the antioxidant Vitamin C. This suggests that the mechanism by which ET-1impairs vascular function and stimulates release of IL-6 involves increased oxidative stress.
Authors: Thomas E Ichim; Boris Minev; Todd Braciak; Brandon Luna; Ron Hunninghake; Nina A Mikirova; James A Jackson; Michael J Gonzalez; Jorge R Miranda-Massari; Doru T Alexandrescu; Constantin A Dasanu; Vladimir Bogin; Janis Ancans; R Brian Stevens; Boris Markosian; James Koropatnick; Chien-Shing Chen; Neil H Riordan Journal: J Transl Med Date: 2011-03-04 Impact factor: 5.531
Authors: A Sánchez; P Martínez; M Muñoz; S Benedito; A García-Sacristán; M Hernández; D Prieto Journal: Br J Pharmacol Date: 2014-12 Impact factor: 8.739
Authors: Christine Susara du Plooy; Catharina Martha Cornelia Mels; Hugo Willem Huisman; Ruan Kruger Journal: Hypertens Res Date: 2016-09-29 Impact factor: 3.872
Authors: Erica M Holt; Lyn M Steffen; Antoinette Moran; Samar Basu; Julia Steinberger; Julie A Ross; Ching-Ping Hong; Alan R Sinaiko Journal: J Am Diet Assoc Date: 2009-03
Authors: Brett S Kirby; Wyatt F Voyles; Carrie B Simpson; Rick E Carlson; William G Schrage; Frank A Dinenno Journal: J Physiol Date: 2009-03-23 Impact factor: 5.182